|
|
|
|
|
|
by dekhn
2115 days ago
|
|
|
As I would classify it, they're running multiple phase 3 trials in multiple countries, but applying policy as if it's one big study (that wasn't clear). An action in the UK study caused all the studies to halt. This is not strictly required, but it's clear they're playing things conservatively. |
|
|